Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

June-16-99

Osteoporosis Drug Decreases Risk for Breast Cancer

According to a study published in The Journal of the American Medical Association, a new drug being tested to combat osteoporosis in premenopausal women has been found to simultaneously fight breast disease. An international study conducted in 180 American hospitals and 24 European health centers found that raloxifene reduced a womanís risk of contracting breast cancer by 76%.

The 3-year breast cancer study followed 7,705 women; 2,557 who received one tablet of raloxifene per day, 2,572 who took two raloxifene pills daily, and 2,576 women who took two placebo pills each day. All the women were under 81 years of age.

Results showed that of the women who received either dose of raloxifene (5,129 women), only 13 cases of breast cancer developed. This compares to 26 cases of breast cancer found in the women who took the dummy pills (2,576 women).

Researchers report that raloxifene "prevents estrogen-related breast cancers by occupying the same molecular receptor sites as the estrogen molecule on the surface of cells. [It] blocks estrogen's cancer promoting effects on breast and endometrial tissue . . ." Scientists are comparing this drug with tamoxifen, a similar drug that also obstructs estrogen on breast tissue.

Side effects of raloxifene included blood clots, hot flashes, flu symptoms, cramps, and swelling of the legs. The results of the study found no differences in the effectiveness of the drug in women who received one or two tablets of raloxifene daily. Currently, the study is continuing in order to examine the long-term effects and usefulness of raloxifene in preventing breast cancer.

Media Resources: New York Times - June 16, 1999


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

11/25/2014 Feminist Majority Foundation President Eleanor Smeal Responds to Ferguson Grand Jury Decision - The following is the statement of Eleanor Smeal, the Founder and President of the Feminist Majority Foundation: "The Feminist Majority Foundation is outraged at the decision not to indict Darren Wilson. This should have been a public trial. . . .
 
11/25/2014 Marissa Alexander Has Accepted a Plea Deal - Marissa Alexander, the woman imprisoned for firing a warning shot in the presence of her abusive husband, chose to accept a plea deal Monday with the state of Florida, pleading guilty to three felony counts of aggravated assault. As part of the plea deal, Alexander received three years imprisonment, but she will be credited for the time she's spent behind bars. . . .
 
11/24/2014 The City of Louisville Has Overwhelmingly Approved a CEDAW Resolution - The city of Louisville, Kentucky approved a resolution that will use the UN Convention on the Elimination of All Forms of Discrimination Against Women (CEDAW) as a framework for all future policy aimed at ending gender-based discrimination. Councilwoman Tina Ward-Pugh introduced the resolution, which passed overwhelmingly on November 6. . . .